# Epoetin Alfa for HIV-Associated Neuropathy Trial

> **NCT00528593** · PHASE2 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- HIV Infections
- Neuropathy

## Interventions

- **DRUG:** epoetin alfa

## Key facts

- **NCT ID:** NCT00528593
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-11
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of pharmaceutical support
- **Last updated:** 2011-08-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00528593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00528593, "Epoetin Alfa for HIV-Associated Neuropathy Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00528593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*